BRITISH JOURNAL OF CANCER

BRITISH JOURNAL OF CANCER

BRIT J CANCER
影响因子:6.8
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:ENGLAND
出版社:Springer Nature
发刊时间:1947
发刊频率:Semimonthly
收录数据库:SCIE/Scopus收录
ISSN:0007-0920

期刊介绍

The British Journal of Cancer is one of the most-cited general cancer journals, publishing significant advances in translational and clinical cancer research. It also publishes high-quality reviews and thought-provoking comment on all aspects of cancer prevention,diagnosis and treatment.
《英国癌症杂志》是被引用最多的综合性癌症期刊之一,发表了转化和临床癌症研究的重大进展。它还发表高质量的评论和发人深省的评论,对癌症的预防,诊断和治疗的各个方面。
年发文量 341
国人发稿量 66.39
国人发文占比 0.19%
自引率 -
平均录取率0
平均审稿周期 平均6月
版面费 US$4480
偏重研究方向 医学-肿瘤学
期刊官网 https://www.nature.com/bjc
投稿链接 https://mts-bjcancer.nature.com/

期刊高被引文献

Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0660-x
Tissue-infiltrating immune cells as prognostic markers in oral squamous cell carcinoma: a systematic review and meta-analysis
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0409-6
Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0542-2
Metabolic reprogramming and Notch activity distinguish between non-small cell lung cancer subtypes
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0464-z
A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0452-3
Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0683-3
The therapeutic potential of targeting tryptophan catabolism in cancer
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0664-6
M2 macrophages mediate sorafenib resistance by secreting HGF in a feed-forward manner in hepatocellular carcinoma
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0482-x
MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0658-4
Genome-wide association study of germline variants and breast cancer-specific mortality
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0393-x
Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0402-0
The impact of psychiatric utilisation prior to cancer diagnosis on survival of solid organ malignancies
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0390-0
ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0637-9
Understanding the impact of socioeconomic differences in colorectal cancer survival: potential gain in life-years
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0455-0
A key genomic subtype associated with lymphovascular invasion in invasive breast cancer
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0486-6
YY1 targets tubulin polymerisation-promoting protein to inhibit migration, invasion and angiogenesis in pancreatic cancer via p38/MAPK and PI3K/AKT pathways
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0604-5
Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0639-7
Increased inflammatory lipid metabolism and anaplerotic mitochondrial activation follow acquired resistance to vemurafenib in BRAF-mutant melanoma cells
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0628-x
Are we over-treating with checkpoint inhibitors?
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0570-y
A novel NPM1-RARG-NPM1 chimeric fusion in acute myeloid leukaemia resembling acute promyelocytic leukaemia but resistant to all-trans retinoic acid and arsenic trioxide
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0456-z
TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0688-y
Understanding of prognosis in non-metastatic prostate cancer: a randomised comparative study of clinician estimates measured against the PREDICT prostate prognostic model
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0569-4
Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancers
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0654-8
Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0665-5
Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0521-7
Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2\u2009+\u2009metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16)
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0618-z
Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0598-z
EWS-FLI1-mediated tenascin-C expression promotes tumour progression by targeting MALAT1 through integrin α5β1-mediated YAP activation in Ewing sarcoma
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0608-1
Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0506-6
Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0694-0
Aberrations in Notch-Hedgehog signalling reveal cancer stem cells harbouring conserved oncogenic properties associated with hypoxia and immunoevasion
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0572-9
Prognostic value of serum alkaline phosphatase in spinal metastatic disease
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0407-8
Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0489-3
Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0426-5
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0492-8
Window of opportunity clinical trial designs to study cancer metabolism
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0621-4
High-resolution imaging mass spectrometry combined with transcriptomic analysis identified a link between fatty acid composition of phosphatidylinositols and the immune checkpoint pathway at the primary tumour site of breast cancer
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0662-8
Predictive values of colorectal cancer alarm symptoms in the general population: a nationwide cohort study
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0385-x
Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0589-0
SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0405-x
Cancer screening and prevention in BRCA mutation carriers: a missed opportunity?
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0484-8
Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0691-3
PLAGL2 promotes epithelial–mesenchymal transition and mediates colorectal cancer metastasis via β-catenin-dependent regulation of ZEB1
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0679-z
Drug responses are conserved across patient-derived xenograft models of melanoma leading to identification of novel drug combination therapies
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0696-y
Comment on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines”
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0576-5
Monozygotic twins with neuroblastoma MS have a similar molecular profile: a case of twin-to-twin metastasis
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0594-3
Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0575-6
Correction: Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0590-7
Breast milk paclitaxel excretion following intravenous chemotherapy—a case report
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0529-z
No evidence for increased prevalence of colorectal carcinoma in 399 Dutch patients with Birt-Hogg-Dubé syndrome
来源期刊:British Journal of CancerDOI:10.1038/s41416-019-0693-1

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
88.56%56.24%-4.28%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q1区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
ONCOLOGY
Q1

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学2区
ONCOLOGY 肿瘤学
2区
2023年12月升级版
医学1区
ONCOLOGY 肿瘤学
2区
2022年12月旧的升级版
医学1区
ONCOLOGY 肿瘤学
2区